Ishwari (Aristolochia Indica): Aristolochic Acid Toxicity — Not a Home Remedy
TL;DR
Ishwari (Aristolochia indica) contains aristolochic acids: kidney toxins and IARC Group 1 carcinogens. Exposure caused kidney failure and urinary-tract cancers; Germany, UK, Canada, Australia, and Taiwan banned such products, while the US FDA warns, blocks imports, and seizes them. Snakebite and fever uses do not make it safe. This article gives no dosage: ishwari is not a home remedy.
What it is
Ishwari is the Ayurvedic name for Aristolochia indica L. (family Aristolochiaceae), a perennial climbing plant of the Indian subcontinent known in English as Indian birthwort. Aristolochic acid I has been reported in its roots, and analyses of A. indica plant samples have detected aristolochic acids I and II (NTP background document; PMC nephrotoxicity review): nitrophenanthrene carboxylic acids reported to be nephrotoxic, mutagenic, and carcinogenic to humans.
Traditional use
Traditional medicine across the Indian subcontinent has used A. indica leaf juice for snakebite and cough, leaves for cholera and children's fevers, and the root, taken as a tonic, emetic, and febrifuge, for fever, digestive complaints, and women's health, including as an emmenagogue and abortifacient, with reported anti-inflammatory and antimicrobial properties (Gajarajan et al., Int J Curr Sci 2023). These are historical uses. Modern toxicology has shown that the plant's signature compounds destroy kidneys and cause cancer: which is why traditional use is documented here as history, not as guidance.
What modern research says
Kidney failure and cancer (human evidence)
Aristolochic acids are genotoxic, they damage DNA directly, and the International Agency for Research on Cancer (IARC) classifies them as Group 1 carcinogens: carcinogenic to humans (PMC review). The US National Toxicology Program likewise lists aristolochic acids as known to be human carcinogens in its Report on Carcinogens (NTP).
The human evidence is unusually direct. In Belgium in the early 1990s, more than 100 women developed rapidly progressive kidney disease, "Chinese herbs nephropathy," now renamed aristolochic acid nephropathy, after taking diet pills in which Stephania tetrandra had been mistakenly replaced by the aristolochic-acid-containing Aristolochia fangchi. Many progressed to end-stage renal failure and urothelial cancer, with aristolochic-acid–DNA adducts found in their kidney tissue proving the exposure (Toxics review, MDPI; CMAJ).
A population-based case–control study in Taiwan then showed that prescribed herbal products containing aristolochic acid were associated with urinary-tract cancer in a dose-dependent manner: and its authors warned that products containing any amount of aristolochic acid may carry substantial cancer risk (JNCI study, PMC).
Regulatory action worldwide
Regulators around the world have moved against aristolochic-acid herbs. Germany's Federal Health Office withdrew all preparations containing aristolochic acids from the market in 1981, exempting only highly diluted homeopathic products (JMPR regulatory review). The United Kingdom also banned Aristolochia species (UC Berkeley summary of NEJM letter). In the United States, the FDA warned consumers to discontinue botanical products containing or suspected to contain aristolochic acid in 2000, urged manufacturers, distributors, and importers to ensure their botanicals were free of it in 2001 (JMPR regulatory review), and moved to block imports of such products (UC Berkeley summary of NEJM letter). The FDA seizes products it believes may contain it (WebMD). Canada directed manufacturers, importers, and retailers to remove all such products in 2001 (CMAJ). Australia's TGA banned the use of all Aristolochia species and any herb that could be mistaken for them (TGA statement via The Limbic). Taiwan banned the herbs in 2003 (JNCI study), and the Chinese Pharmacopoeia has excluded aristolochic-acid-containing Aristolochia medicines since 2003 (Toxins review, MDPI). IARC's classification of Aristolochia-containing herbal remedies as Group 1 carcinogens dates to 2002 (JNCI study).
What the evidence does not support
There is no safe dose of aristolochic acid and no human efficacy evidence that could justify the risks. The traditional indications, snakebite, fever, menstrual stimulation, belong to an era before the kidney and cancer toxicity was understood.
Dosage
This article provides no dosage and no preparation instructions. There is no amount of ishwari that toxicology considers safe: epidemiological data suggest even small exposures carry cancer risk. Do not consume this plant in any form.
Safety & contraindications
- Taken by mouth, Aristolochia is unsafe for everyone: it is toxic to the kidneys and causes cancer. Use can cause kidney damage leading to dialysis or transplant, and greatly increases the risk of bladder and other urinary-tract cancers (WebMD).
- It is unsafe in pregnancy and breastfeeding, and may bring on early kidney failure in people with existing kidney disease (WebMD).
- It can compound kidney damage from other kidney-harming drugs, including certain antibiotics, NSAIDs, and cyclosporine (WebMD).
- Because contamination and species substitution have caused poisonings before (the Belgian tragedy began with one herb mistaken for another), be wary of any traditional or imported remedy listing birthwort, Aristolochia, or ishwari among its ingredients.
FAQs
What is ishwari?
Ishwari is Aristolochia indica, or Indian birthwort: a climbing plant of the Indian subcontinent used in traditional medicine, now known to contain aristolochic acids, which are nephrotoxic, mutagenic, and carcinogenic to humans (NTP background document; PMC review).
Why is ishwari banned?
Because its aristolochic acids caused an epidemic of kidney failure and urinary-tract cancers, most notoriously in Belgian women taking contaminated diet pills in the 1990s, and because IARC classifies them as carcinogenic to humans. Regulators in the US, UK, Germany, Canada, Australia, Taiwan, and China have all acted against aristolochic-acid products (MDPI review; JNCI study).
Is there a safe dose of ishwari?
No. A Taiwanese population study found urinary-tract cancer risk rose with dose and warned that products containing any amount of aristolochic acid may carry substantial risk (JNCI study).
But Ayurveda used it for snakebite — doesn't that count for something?
It counts as history. Traditional physicians did not know about aristolochic-acid nephropathy or its DNA-damaging, cancer-causing mechanism; modern toxicology and epidemiology do. A traditional indication does not override proven kidney and cancer toxicity.
I may have taken a product containing ishwari or birthwort — what should I do?
Stop taking it and see a doctor. Mention aristolochic-acid exposure specifically so kidney function can be monitored; kidney damage from these compounds can be silent until advanced (WebMD).
Sources
- Zhang H. et al. "Aristolochic acid-induced nephrotoxicity: molecular mechanisms and potential protective approaches." PMC — PMC · PMC7043226
- "Aristolochic acids: newly identified exposure pathways of this class of environmental and food-borne contaminants." Toxics (MDPI) — mdpi.com
- Chen C.-H. et al. "Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk." Journal of the National Cancer Institute, via PMC — PMC · PMC2815723
- "Comparative analysis of aristolochic acids in Aristolochia medicinal herbs." Toxins (MDPI) — mdpi.com
- U.S. National Toxicology Program. Report on Carcinogens (12th ed.): aristolochic acids listed as "known to be human carcinogens" — ntp.niehs.nih.gov
- "Legislative and regulatory actions on aristolochic acids." J Med Plants Res. — ftp.academicjournals.org
- "Several Chinese herbal products may contain toxic aristolochic acid." CMAJ. 2004;171(5):449 — cmaj.ca
- U.S. National Toxicology Program. Background document: Report on Carcinogens — Aristolochic Acids (2010). Tables A. indica among species used in botanical products with aristolochic-acid components (AA I, IVa, IVa methyl ester lactam; aristolic acid in root) — ntp.niehs.nih.gov
- Gajarajan M. et al. "Aristolochia indica L. is Endangered Species in Red Data Book, but growing in South India." Int J Curr Sci. 2023;13(1):332–338 (botany, traditional uses, chemical constituents) — rjpn.org
- UC Berkeley. "Dangerous herbal readily available through Web despite FDA import ban" (summary of Gold & Slone NEJM letter, 2003) — newsarchive.berkeley.edu
- TGA statement on banning all aristolochia species, via The Limbic — thelimbic.com
- "Aristolochia: overview, uses, side effects, precautions." WebMD — webmd.com
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Ishwari (Aristolochia indica) contains aristolochic acid, a proven kidney toxin and human carcinogen. Do not consume this plant in any form or amount. If you have taken a product that may contain ishwari, birthwort, or Aristolochia, stop taking it and consult a doctor promptly. Herbal products can interact with medications and are not suitable for everyone; talk to a qualified healthcare practitioner before using any herb.